PL1808170T3 - Wodne krople do oczu z przyśpieszoną migracją wewnątrzgałkową - Google Patents

Wodne krople do oczu z przyśpieszoną migracją wewnątrzgałkową

Info

Publication number: PL1808170T3
Authority: PL; Poland
Prior art keywords: aqueous eye; accelerated; eye drop; eye drops; aqueous
Prior art date: 2004-11-05

Application number

PL05805529T

Other languages

English (en)

Inventor

Shirou Sawa

Tomoko Nakajima

Original Assignee

Senju Pharma Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-11-05

Filing date

2005-11-04

Publication date

2011-12-30

2005-11-04 Application filed by Senju Pharma Co filed Critical Senju Pharma Co

2011-12-30 Publication of PL1808170T3 publication Critical patent/PL1808170T3/pl

Links

239000003889 eye drop Substances 0.000 title abstract 4
229940012356 eye drops Drugs 0.000 title 1
230000005012 migration Effects 0.000 title 1
238000013508 migration Methods 0.000 title 1
ZBPLOVFIXSTCRZ-UHFFFAOYSA-N bromfenac Chemical compound NC1=C(CC(O)=O)C=CC=C1C(=O)C1=CC=C(Br)C=C1 ZBPLOVFIXSTCRZ-UHFFFAOYSA-N 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
150000001412 amines Chemical class 0.000 abstract 1
210000001742 aqueous humor Anatomy 0.000 abstract 1
208000027866 inflammatory disease Diseases 0.000 abstract 1
XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 abstract 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 abstract 1
229960000281 trometamol Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL05805529T 2004-11-05 2005-11-04 Wodne krople do oczu z przyśpieszoną migracją wewnątrzgałkową PL1808170T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2004322569		2004-11-05
PCT/JP2005/020302 WO2006049250A1 (ja)	2004-11-05	2005-11-04	眼内移行性促進水性点眼剤
EP05805529A EP1808170B1 (en)	2004-11-05	2005-11-04	Aqueous eye drops with accelerated intraocular migration

Publications (1)

Publication Number	Publication Date
PL1808170T3 true PL1808170T3 (pl)	2011-12-30

Family

ID=36319250

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05805529T PL1808170T3 (pl)	2004-11-05	2005-11-04	Wodne krople do oczu z przyśpieszoną migracją wewnątrzgałkową

Country Status (11)

Country	Link
US (3)	US20070021507A1 (pl)
EP (1)	EP1808170B1 (pl)
JP (1)	JP4933897B2 (pl)
KR (2)	KR20130080061A (pl)
CN (1)	CN1993118B (pl)
AT (1)	ATE520394T1 (pl)
CA (1)	CA2560559C (pl)
ES (1)	ES2369089T3 (pl)
MX (1)	MX2007001172A (pl)
PL (1)	PL1808170T3 (pl)
WO (1)	WO2006049250A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI465236B (zh) *	2007-03-13	2014-12-21	參天製藥股份有限公司	含有吡諾克辛之懸浮型水性液劑
CN101313899B (zh) *	2007-06-01	2012-02-29	北京德众万全药物技术开发有限公司	一种含有溴芬酸钠的眼用药物组合物
WO2009117086A2 (en) *	2008-03-17	2009-09-24	Cardiac Pacemakers, Inc.	Deactivation of intermittent pacing therapy
JP5219879B2 (ja) *	2009-02-20	2013-06-26	倉敷紡績株式会社	ｌｏｇＰの決定方法、および該方法に使用される二相系溶媒
US8778999B2 (en)	2009-03-05	2014-07-15	Insite Vision Incorporated	Non-steroidal anti-inflammatory ophthalmic compositions
EP2269575A1 (en) *	2009-06-30	2011-01-05	Santen Pharmaceutical Co., Ltd	Method for improving bioavailability of latanoprost
CN102557976B (zh) *	2010-12-15	2015-06-10	辽宁盛京制药有限公司	溴芬酸有机盐及其制备方法、其组合物及用途
MX341189B (es) *	2011-01-18	2016-08-09	Senju Pharma Co	Composicion liquida y acousa de bromfenaco, que tiene efectividad conservadora.
JP6012231B2 (ja) *	2011-04-08	2016-10-25	ロート製薬株式会社	ブロムフェナク含有組成物
US20160143869A1 (en) *	2013-06-19	2016-05-26	Sentiss Research Center	Stable bromfenac solution
TW201601717A (zh) *	2013-09-26	2016-01-16	參天製藥股份有限公司	含有經安定化之２－胺基－３－（４－溴苯甲醯基）苯基醋酸之水性組成物
KR20190137788A (ko)	2017-02-21	2019-12-11	티얼솔루션즈, 인크.	안정한 펩타이드 조성물
CN111743858B (zh) *	2019-03-29	2023-06-27	天津药业研究院股份有限公司	一种溴芬酸钠的药物组合物
CN112823784B (zh) *	2019-11-20	2022-09-16	湖北远大天天明制药有限公司	吡诺克辛钠滴眼液以及用于眼部给药的溶液

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2860160A (en) *	1956-11-19	1958-11-11	Gen Aniline & Film Corp	Preparation of aminoalkyl acids and derivatives thereof
JPS5989616A (ja)	1982-11-15	1984-05-23	Lion Corp	点眼液
JPS5989617A (ja)	1982-11-15	1984-05-23	Lion Corp	点眼液
JPS6112617A (ja)	1984-06-27	1986-01-21	Lion Corp	点眼液
US4563291A (en) *	1984-07-20	1986-01-07	Halliburton Company	Method of preparation of substituted amino-alkyl sulfonic acid compounds and use in the treatment of subterranean formations
DE3612537C1 (de) *	1986-04-14	1987-07-16	Dispersa Ag	Arzneimittel zur Behandlung von Entzuendungen im Auge
DE3612538A1 (de)	1986-04-14	1987-10-15	Dispersa Ag	Stabilisierung von quecksilberhaltigen konservierungsmitteln in augentropfen
JP2563336B2 (ja)	1987-06-01	1996-12-11	エーザイ株式会社	角膜透過促進点眼剤
CA1325382C (en) *	1988-01-27	1993-12-21	Takahiro Ogawa	Locally administrable therapeutic composition for inflammatory disease
US5849291A (en) *	1994-10-17	1998-12-15	Symbollon Corporation	Opthalmic non-irritating iodine medicament
US5639481A (en) *	1994-10-17	1997-06-17	Symbollon Corporation	Method for the therapeutic treatment of a mammalian eye using an admixed composition containing free molecular iodine
US5603929A (en) *	1994-11-16	1997-02-18	Alcon Laboratories, Inc.	Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
AU695322B2 (en) *	1994-12-19	1998-08-13	Taisho Pharmaceutical Co., Ltd.	Liposome eye drops
US5558876A (en) *	1995-03-29	1996-09-24	Alcon Laboratories, Inc.	Topical ophthalmic acidic drug formulations
JP3170619B2 (ja) *	1995-04-20	2001-05-28	参天製薬株式会社	有機アミンを配合したプラノプロフェン点眼液
CN1124842C (zh)	1997-11-05	2003-10-22	千寿制药株式会社	缓释滴眼剂
US6645963B2 (en) *	1997-11-05	2003-11-11	Senju Pharmaceutical Co., Ltd.	Prolonged-action eye drop
JP4309974B2 (ja)	1998-05-21	2009-08-05	日油株式会社	眼科用製剤
PE20020146A1 (es) *	2000-07-13	2002-03-31	Upjohn Co	Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
JP4752987B2 (ja) *	2000-10-12	2011-08-17	ライオン株式会社	外用剤組成物
US20040120916A1 (en) *	2002-12-23	2004-06-24	Advanced Medical Optics, Inc.	Contact lens care compositions, methods of use and preparation which protect ocular tissue membrane integrity
US8129431B2 (en)	2003-01-21	2012-03-06	Senju Pharmaceutical Co., Ltd.	Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
DE602004023516D1 (de) *	2003-08-07	2009-11-19	Allergan Inc	Zusammensetzungen zur abgabe von therapeutika in die augen und verfahren zu ihrer herstellung und verwendung
WO2005046700A1 (ja)	2003-11-14	2005-05-26	Senju Pharmaceutical Co., Ltd.	アミノグリコシド系抗生物質およびブロムフェナクを含有する水溶液製剤

2005
- 2005-11-04 WO PCT/JP2005/020302 patent/WO2006049250A1/ja not_active Ceased
- 2005-11-04 CN CN2005800259636A patent/CN1993118B/zh not_active Expired - Fee Related
- 2005-11-04 MX MX2007001172A patent/MX2007001172A/es active IP Right Grant
- 2005-11-04 JP JP2006542445A patent/JP4933897B2/ja not_active Expired - Fee Related
- 2005-11-04 PL PL05805529T patent/PL1808170T3/pl unknown
- 2005-11-04 AT AT05805529T patent/ATE520394T1/de active
- 2005-11-04 EP EP05805529A patent/EP1808170B1/en not_active Expired - Lifetime
- 2005-11-04 CA CA2560559A patent/CA2560559C/en not_active Expired - Fee Related
- 2005-11-04 KR KR1020137015731A patent/KR20130080061A/ko not_active Ceased
- 2005-11-04 ES ES05805529T patent/ES2369089T3/es not_active Expired - Lifetime
- 2005-11-04 US US10/568,418 patent/US20070021507A1/en not_active Abandoned
- 2005-11-04 KR KR1020067022310A patent/KR101312740B1/ko not_active Expired - Fee Related
2011
- 2011-12-21 US US13/332,827 patent/US8299124B2/en not_active Expired - Fee Related
2012
- 2012-09-14 US US13/616,810 patent/US8518996B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20120095101A1 (en)	2012-04-19
WO2006049250A1 (ja)	2006-05-11
US20130005815A1 (en)	2013-01-03
ATE520394T1 (de)	2011-09-15
JPWO2006049250A1 (ja)	2008-05-29
ES2369089T3 (es)	2011-11-25
EP1808170A4 (en)	2008-03-12
EP1808170B1 (en)	2011-08-17
JP4933897B2 (ja)	2012-05-16
CA2560559C (en)	2013-07-02
EP1808170A1 (en)	2007-07-18
CN1993118B (zh)	2010-06-16
MX2007001172A (es)	2007-03-12
CN1993118A (zh)	2007-07-04
US20070021507A1 (en)	2007-01-25
US8299124B2 (en)	2012-10-30
US8518996B2 (en)	2013-08-27
KR20130080061A (ko)	2013-07-11
CA2560559A1 (en)	2006-05-11
KR20070073600A (ko)	2007-07-10
KR101312740B1 (ko)	2013-09-27

Publication	Publication Date	Title
EP1808170A4 (en)	2008-03-12	AQUEOUS EYE DROPS WITH ACCELERATED INTRAOCULAR MIGRATION
AU2017210644B2 (en)	2019-04-04	Autoimmune disorder treatment using RXR agonists
EA201000441A1 (ru)	2010-10-29	Водные офтальмологические препараты
BRPI0413075A (pt)	2006-10-03	sistema de lente intra-ocular primária e suplementar
NO20083710L (no)	2008-11-18	Dihydrotienopyrimidin for behandling av betennelsesforstyrrelser
ATE275552T1 (de)	2004-09-15	1-substituierte-1-aminomethyl-cycloalkan derivate (= gabapentin analoga), deren herstellung und deren verwendung bei der behandlung von neurologischen erkrankungen
CY1117094T1 (el)	2017-04-05	Παραγωγα 2-φαινυλαιθυλαμινης ως τροποποιητες του διαυλου ασβεστιου και/ή νατριου
ATE322895T1 (de)	2006-04-15	Coenzym q10 zur behandlung von erkrankungen der augen
BR0213970A (pt)	2004-08-31	Amidas de ácido antranìlico e uso farmacêutico dessas amidas
PH12021551412A1 (en)	2022-05-02	Ursodeoxycholic acid-containing agent for treating or preventing presbyopia
AU2003249575A8 (en)	2003-12-02	A process for preparing pharmaceutical compositions containing 4-aminoquinolines compounds for treatment of inflammatory disorders of the eye and compositions resulting therefrom
ATE210980T1 (de)	2002-01-15	Verwendung von indolderivaten zur behandlung von dermatologischen krankheiten, peridhren neuropathien, arthritis, allergischen oder chronisch-obstruktiven atemwegserkrankungen, glaukom und augenentzündungen
KR950032171A (ko)	1995-12-20	옥소피리디닐퀴녹살린 유도체
MY136322A (en)	2008-09-30	Anthranilic acid amides and pharmaceutical use thereof
ATE444754T1 (de)	2009-10-15	Verwendung von tyrosinkinase-inhibitoren zur behandlung inflammatorischer prozesse
ES2118842T3 (es)	1998-10-01	Derivados del acido aminobenzoico.
RU2019118904A (ru)	2021-01-18	Распределение в глазу и фармакокинетика композиций лифитеграста
CY1121044T1 (el)	2019-12-11	Συνθεσεις και μεθοδοι για τη θεραπεια οφθαλμικων διαταραχων
BRPI0517972A (pt)	2008-10-21	ácido 5,6,7-triidroxiheptanóico e análogos para o tratamento de doenças oculares e doenças associadas com respostas hiperproliferativas e angiogênicas
MXPA02011481A (es)	2003-06-06	Derivados de disulfuro que son utiles para el tratamiento de enfermedades alergicas.
PT1289945E (pt)	2004-10-29	Derivados dissulfureto de anilina para o tratamento de doencas alergicas
DE60327179D1 (de)	2009-05-28	Behandlung von augenkrankheiten mit harnstoff und harnstoffderivaten
CA2468811A1 (en)	2003-07-31	Pharmaceutical use of cox-2 inhibitors in angiogenesis-mediated ocular disorders
ATE428709T1 (de)	2009-05-15	Anthranilsäureamide und ihre pharmazeutische verwendung
TW200724138A (en)	2007-07-01	Substituted carboxylic acid derivatives for the treatment of diabetes and lipid disorders, their preparation and use